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Acute Leukemia Immunophenotyping with
Pakistani Perspective
Dr Shahid Pervez, Histopathology
Immunophenotyping is currently an integral part of
modalities in diagnosis of acute leukemia along with
morphology, cytochemistry and cytogenetics. However
in financially constrained regions like Pakistan,
judicious usage in a cost-effective manner is of
paramount importance.
Primary goals for immunophenotyping in acute
leukemia are lineage assignment of blasts and further
sub-classification. Secondary goals include
prognostication and minimal residual disease
assessment.
We recommend performing immunophenotyping after
meticulous morphological assessment and
histochemistry. This would help in the selection of
panels in a cost -- effective fashion.
The following approaches are used in various
laboratories:
·
Upfront (single) comprehensive panel (Fig. 1, 2
and 3)
·
Primary screening panel followed by secondary
directed panel

Figure 1: A comprehensive panel in a child with acute leukemia.
Note blast gating on CD45 dim population. This population is
showing prominent reactivity with B cell markers cCD79a, CD19,
CD20, CD10, CD22 & cTdt along with HLA-DR consistent with
'Commen Pre-B-All'.

The second approach is more suitable in our scenario as
it reduces the cost without compromising diagnosis.
Here, primary panel composed of most sensitive
markers for each lineage is able to diagnose most
leukemias without additional testing. This should be as
minimal a panel as necessary.
Following panels are recommended by Histopathology
Section of AKUH,:
Primary Panel
B-cell:
CD19 and CD10
T-cell:
CD7 and CD3 (cyto)
Myeloid: CD13 and CD33
Figure 2: A comprehensive panel in a young, adult with acute
leukemia. Note blast gating on a CD45 dim population. This
population is showing prominent reactivity with T-Cell markers
CD3, CD5 and CD7 along with cTdt consistent with 'Pre-T-ALL'.

2

Secondary Panel
B- Cell:
CD20, CD22, cCD79a, IgG, IgM, Kappa,
lambda, HLA-DR and Tdt
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T-Cell:
Myeloid:

CD5, CD4, CD8, CD56, HLA-DR and Tdt
MPO, CD14, HLA-DR, CD117, CD61

All samples must be tested for viability and gating
(selecting) of the blast population by Leucogate. This is
using CD45 (LCA) with side scatter (SS) and as blast
population is invariably dim for CD45, it can be selected
for further analysis.
Samples of bone marrow or blood should be obtained
fresh possibly not over 48 hours in heparanised or EDTA
tubes (3-4 cc). Transportation from different cities and
distant or remote areas should be according to the
defined guidelines. It is necessary that a viability check
be performed on arrival of sample before proceeding
further.

Figure 3: A comprehensive panel in a middle-aged patient with
acute leukemia. Note blast gating on CD45 dim population. This
population is showing prominent reactivity with myeloid markers
cMPO, CD13 CD33 & CD14 alongwith HLA-DR consistent with
'Acute myelomonocytic leukemia (M4)'.

PAX5: Immunohistochemistry Marker for B cell
Lymphoproliferative Disorders
Muhammad Rahil Khan; Arsalan Ahmed, Histopathology
PAX5 (B-cell-specific activator protein, BSAP) is a
leukemia, lymphoma and post-Rituxamab treatment. In
member of the paired-box domain gene family that
addition to its expression in B cells, PAX5 protein
encodes nuclear transcription
and/or mRNA have been
factors. The latter are
reported to be expressed in
important in development,
neoplasms of central nervous
differentiation, cell migration
system, testis and bladder.
and proliferation of B
lymphocytes. PAX5 protein is
PAX5 is the most sensitive and
expressed as a nuclear marker
reliable immunohistochemical
in B-lineage cells that span the
marker for B cell malignancies
differentiation spectrum in
since PAX5 will always be
pro-, pre-, and mature B cells,
expressed in the absence of
but are not expressed in
expression of other pan - B plasma cells at all. Hence,
cell markers, suggesting that
PAX5 protein is also a useful
the inclusion of PAX5 in a
lineage-specific marker in
panel of antibodies to diagnose
hematopoietic neoplasms
B cell lymphomas would be
arising from B cells.
very helpful. AKUH
Figure 1:Bone trephine biopsy showing diffuse positivity to PAX5
Laboratory has recently added
Staining for PAX5 has utility
this marker in the
in the diagnosis of B cell malignancies that lack
immunohistochemistry profile for tumors and
expression of commonly used pan-B-cell markers such
lymphoproliferative disorders
as CD20 and CD79a, especially acute lymphoblastic
3
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Understanding the Water Deprivation Test
Dr Lena Jafri, Chemical Pathology

Water Deprivation Test is performed to distinguish
among the two major forms of Diabetes Insipidus (DI):
Central and Nephrogenic.

An unusual form of transient ADH-resistance disorder
is gestational DI that is observed in selected women
during the second half of pregnancy. Pregnancy is
associated with release of a vasopressinase from the
placenta. This leads to rapid degradation of endogenous
or exogenous ADH, but not of desmopressin. These
women also present with polyuria.

Central DI results from trauma or
tumor in pituitary gland with
subsequent failure of the posterior
pituitary to secrete ADH. Rarely, it
can be familial due to mutation in
ADH gene. This is an autosomal
dominant disorder leading to
misfolded ADH precursors which
are not stable and are destroyed
easily.

Plasma ADH, pg/mL

DI results from the deficiency or functional resistance of
a pituitary hormone known as Antidiuretic hormone
(ADH) or vasopressin. ADH helps in conserving water
by the kidneys . Consequent to low
or subnormal ADH, the kidneys
are unable to retain water during
filtering blood resulting in
polyuria. Hence, urine output may
12
exceed three litres in a day in
2
adults and two litres/m in children.
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In contrast to central type, ADH
secretion is normal in nephrogenic
DI but is associated with varying
degrees of renal resistance to its
water retaining effect. Causes of
Nephrogenic DI can be structural
kidney defects due to hypercalcaemia, hypokalaemia
and chronic lithium usage or mutations in auaporin-2
gene or AVPR2 gene. [There are two different receptors
for ADH: the V1 (AVPR1) and V2 (AVPR2) receptors.
The AVPR2 gene is located on the X-chromosome (Xq28).]
Differential diagnosis of DI includes other causes of
polyuria such as diabetes mellitus and, chronic renal
failure (caused by osmotic diuretics, glucose and urea).
Psychogenic polydipsia is an important cause of
polyuria, which usually occurs in anxious middle-aged
women, psychiatric illnesses, individuals taking
phenothiazines causing dry mouth.
4
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Figure 1: Relation between ADH and plasma Osmolality

The cause of polyuria is often suggested from the history,
for example age of onset and eliciting the possible
presence of the different causes of DI, and rarely by the
plasma sodium concentration. Polyuria due to lack of
ADH usually exceeds 5 litres daily. In DI there is a
tendency for the serum osmolality to be increased above
normal; the reverse is true in compulsive water drinkers.
Specific testing is then performed to establish the
diagnosis.
Water Deprivation Test helps in the diagnosis of DI. It is
performed under constant medical supervision as it can
potentially cause dehydration, fluid and salt imbalance.
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Now ADH (Desmopressin 10
microgram nasal insufflations
or 4 microgram subcutaneously
or 5 units of aqueous
vasopressin subcutaneously) is
given. One hour later urine is
collected for urine osmolality
estimation.

Start Water
Deprivation

Administer dDavp
or Vasopressin

Normal

1000
Urine Osmolality, mmol/kg

Water is restricted from 9:00 pm
the night before the test until
conclusion of the test. At 7:00
am the next morning the bladder
is emptied and this urine is
discarded. The patient is
weighed and is told to pass urine
hourly beginning at 8:00 am.
Urine osmolality is estimated
and the test is continued until
urine osmolality reaches 750
mmol/L or it reaches a plateau.
(Plateau is the difference
between consecutive
estimations of urine osmolality
of less than 30 mmol/kg). When
plateau is reached blood sample
is drawn for serum osmolality.

Partial Central Dl
Partial Nephrogenic Dl or
Psychogenic Polydipsia

500

Complete Central Dl
Complete Nephrogenic Dl

200

280

295

Plasma Osmolality, mmol/kg

Aga Khan Hospital Clinical
Laboratory should be notified the day before testing to
arrange for stat determinations of urine and serum
osmolality and for immediate processing of plasma
vasopressin.
The test is discontinued if urine osmolality is stable on
two or three successive measurements despite a rising
plasma osmolality or if the plasma osmolality exceeds
295 to 300 mosmol/kg. The test is also halted if the
patient loses >5% of their body weight.
Accurate interpretation of the water restriction test
generally requires that exogenous ADH not be given
before the urine osmolality has been stabilized or the
plasma osmolality has reached 295 mosmol/kg. Below
this level, maximum endogenous ADH effect may not
be present and an antidiuretic response to ADH is of no
diagnostic benefit, since it will raise the urine osmolality
even in normal subjects (Figure 1). Central DI is usually

Figure 2: Interpretation of Water Deprivation Test

partial. In the case of Central DI both ADH release and
urine osmolality may increase as the plasma osmolality
rises, but sub-maximally. Exogenous ADH will lead to a
rise in urine osmolality of more than 100% in complete
Central DI and 15 to 50% in partial Central DI (Figure 2).
Nephrogenic DI is also associated with sub-maximal
rise in urine osmolality in response to water restriction.
Elevation in plasma osmolality stimulates ADH release.
Most patients with acquired Nephrogenic DI are
resistant to ADH hence no response is seen. If the history
and water restriction test provide equivocal results
plasma samples collected at baseline and following
water deprivation (prior to ADH administration) are
sent for measurement of ADH.
Note: This test can be done only under medical
supervision as it can potentially cause dehydration,
fluid and salt imbalance.
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Gonadotropins Releasing Hormone (GnRH)
Stimulation Test
Dr Noreen Sherazi, Chemical Pathology
The hypothalamic gonadotropin releasing hormone
(GnRH) stimulates release of both luteinizing hormone
(LH) and follicle stimulating hormone (FSH) in normal
individuals. Subnormal responses are seen in some
patients with pituitary and hypothalamic disorders.
However, the magnitude of FSH and LH response to
GnRH is usually predictable from the basal FSH and LH
levels.
GnRH stimulation test is useful in patients in whom the
clinical picture and basal gonadotropins measurements
are inconclusive. It is indicated in patients with
precocious puberty (suspect pathologic central cause)
and delayed puberty (suspect hormonal cause)
The test may be performed without regard for previous
feeding or time of day. After patient's consent, baseline
specimens are obtained for LH and FSH determination.

After that 100 µg of synthetic GnRH is given
intramuscularly or intravenously, followed by sampling
for serum levels of FSH and LH at 30, 45, 60 minutes
(can be taken up to 180 minutes).
Instruction about use of medicine, dose and timings
of samples can be followed as per physician request.
Peak responses to both FSH and LH occur between 30
and 45 minutes. Patients with pituitary disorders may
have normal, diminished or absent response. Normally
LH response should increase by 3-10 fold. The FSH
response is of lesser magnitude, usually 1.5-3 fold
increase in patients with hypothalamic disorders; the
response may be exaggerated, normal, diminished or
absent. In the case of Gonadotropins-independent
precocious puberty, no increase over basal levels is
observed. FSH and LH response is termed flat.

Haematology Quiz
Drs Natasha Ali, Kashif Khan, Haematology
A seven-year old child presented to haematology clinic
with complaints of fever and failure to thrive since two
months. Past history was significant for repeated upper
respiratory infections. Examination revealed pallor.
There was no hepatosplenomegaly. A complete blood
count showed hemoglobin of 6.2 gm/dl, haematocrit

19%, normal red cell indices. WBC of 3.7 x10E9/L,
ANC 1.6 x 10E9/L and Platelets 122 x 10E9/L.
Peripheral blood picture is attached. Please comment on
the peripheral film and give your most probable
diagnosis
6
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Red Cell Mass Study
Dr Izza Hussain, Haematology

Red cell mass (RCM) is the measurement of total
volume of erythrocytes in the body. Its significance lies
in the fact that Polycythemia Vera Study Group (PVSG)
requires RCM to be measured for the diagnosis of
polycythemia rubra vera (PRV) - a myeloproliferative
disorder that is associated with absolute increase in red
cells. The International Council for Standardization in
Haematology (ICSH) has recommended that blood
volume should be calculated in terms of body surface
area.
RCM studies are based on dilutional analysis. The
patient red cells are labeled with radioactive sodium
chromate (Cr51) and injected intravenously. The
dilution is measured after allowing sufficient time for
Cr51 tagged red cells to become thoroughly mixed in
circulation. From the dilution, the total blood volume of
red cells can be calculated. Results are recorded as
counts per seconds (cps) and background counting is
measured by gamma counter. RCM is then calculated

using body surface area.
It is considered elevated if it is >25% above the mean
expected value. False positive results can be observed in
obese patients with PRV who has had significant
recovery or during gastrointestinal blood loss.
Red cell mass study helps to differentiate between
absolute and apparent erythrocytosis. The former is the
absolute raised red cell mass with normal plasma
volume while the latter is spuriously high red cells
counts secondary to reduced plasma volume. RCM is
required for establishing the diagnosis of PRV. It is one
of the chronic myeloproliferative disorders
characterised by clonal proliferation of myeloid cells
distinguished clinically from other myeloprpliferative
disorders by the presence of increased red cell mass
which results in increased red cell counts, elevated
haemoglobin and increased haematocrit (packed cell
volume).

Diagnostic Criteria for PRV
Major
! Increase red cell mass (25% above predictive value or PCV > 60 in males and 56 in females)
!
Arterial oxygen saturation > 92% with no elevation of serum erythropoietin (EPO) concentration
!
Palpable Splenomegaly
!
Acquired clonal genetic abnormality except BCR-ABL fusion
Minor
9
!
Platelet count > 400 X 10 /L
!
WBC count > 10 X 109/ L or 12 X 109/ L in smokers
!
Radiological splenomegaly
!
Endogenous erythroid colonies or low EPO
Diagnosis of PRV requires presence of two major
criteria or presence of any major with any two minor
criteria. Additionally, presence of JAK-2 mutation
(exon 14 or 12), Karyotyping abnormality other than

1.
2.

3.
4.

t9:22, bone marrow biopsy showing hyper cellularity
with prominent erythroid, granulocytes and
megakaryocyte proliferation with characteristic
absence of storage iron may be required for diagnosis.

What should a patient know before RCM studies?
It is a sufficiently long test requiring at least 2.5 hours for completion
Ionic dyes are sometimes allergic, but this is a radio nucleotide scanning, it will not affect the patient's health
(amount of chromium used in the study is <2 ìg/ml while toxic level is > 10 ìg/ml to inhibit glycolysis and > 5ìg/ml
to inhibit glutathione reductase)
Getting the blood back after tagging is part of the study and all the aseptic techniques are employed to ensure safety
During travelling, the patient will not be detected by metal detectors
7
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Semen Analysis: An Invaluable Tool for
Infertility Work-up
Azra Ali and Dr Shahid Pervez, Histopathology
Semen analysis is the most useful front-line test in the
fertility work-up in males. It is essential that semen is
collected according to pre-defined strict guidelines, so

that a true picture of the fertility status may emerge. The
test is simple, cheap, non-invasive and most informative.

Sample Collection Guidelines

1. The sample should be collected after a minimum of 48 hours but no longer than seven days of sexual
abstinence
2. Ideally the sample should be collected in the laboratory but if this is not possible it should be delivered to the
laboratory within one hour of collection
3. The sample should be protected from extremes of temperature (less then 20°C - more then 40°C) during
transportation
4. The sample should be obtained by masturbation into a clean, wide-mouth container (available at AKUH lab
points)
5. The container must be adequately labeled with the subject's name and identification number

Like all biological specimens, semen samples may
contain harmful infectious agents (for example HIV,
hepatitis B) and should therefore be handled carefully. A
normal semen sample liquefies within 60 minutes at
room temperature, although in most cases this occurs
within 15 minutes. After liquefaction the physical and
microscopic examination is performed.
The semen contains spermatozoa and seminal plasma
which is a semi-gelatinous fluid. Testis produce
spermatozoa while the assessory glands namely the
epididymis, prostate, seminal vesicles and bulbourethral glands produce the seminal plasma.
The first part of ejaculate contains most of the

8

spermatozoa suspended in prostatic and epididymal
fluid while its last part has residual spermatozoa
suspended in the vesicular fluid.
The spermatozoa constitute only 1-5% of the total
ejaculate. Spermatozoon is a unique cell which neither
grows nor divides. It consists of a head, a mid piece and a
tail. It is a highly specialised cell with considerable
power of movement in order to complete its task of
fertilisation of the oocyte.
Physical characteristics of semen like appearance,
volume, viscosity are noted. Its pH is measured and
microscopic examination is also performed and
reported.
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Normal Values for Human Ejaculate
Volume
PH
concentration
motility
morphology
WBC

>2.0 ml
7.2-7.8
20 x 106 spermatozoa/ml or more
>50%
>30% with normal morphology
<1.0 millions/ml

Microscopic
Examination
This is done to estimate
total sperm count as well
as percentage of motile
sperms. Motility of the
spermatozoa like rapid
linear progression,
slow/non linear
progression and non
progressive sperms. On
morphology defects of
head ( e.g. large, small
tapered pyriform, round
and amorphous heads),
neck and mid-piece
(namely bent head, thick
mid-piece) and tail ( such
as
short, multiple
hairpins and bent tail) are
noted.

Figure shows: 1-Normal, 2-Pyriform head, 3-Normal, 4-Amorphous head, 5-Bent head, 6-Amorphous head with thick
mid-piece. (Acquired from WHO Lab. Manual - 1)

Nomenclature for Semen Variables
Azoospermia: Total absence of sperms in an ejaculate
Oligozoospermia: Reduced number of sperms in semen (less then 20 millions/ml)
Polyzoospermia: Increased number of sperms in semen (greater then 200 millions/ml)
Normozoospermia: Normal sperm counts
Aspermia: Total absence of an ejaculate
Haematospermia: The presence of blood in semen
Leukocytospermia: White Blood Cells in the semen
9
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Foetal Anomaly Scan
Dr Shaista Afzal; Muhammad Owais Khan, Radiology

Foetal Anomaly Scan is done at Aga Khan University
Hospital with dedicated appointment and time slot.

appropriate and timely intervention and thus can
decrease the tremendous psychological trauma and
financial burden on the family and society.

The objective of this scan is to examine the anatomy of
foetus and assessing its normal growth along with
The foetal anomaly scan is done to reassure a woman
evaluation of placental position. The structures
that her baby has no structural abnormalities. It aids to
examined include the brain, spine, heart, kidneys, lips,
identify anomalies not compatible with life or those that
legs, feet, lungs, stomach, kidneys, bladders, umbilical
are associated with
cord and limbs. The liquor
morbidity or disability. Most
volume will also be assessed
of the time, the scan will not
at the same time. Foetal
review any abnormality. In
anomalies are sometimes
fact, 98% of babies born are
associated with abnormal
normal. If an abnormality is
liquor volume. A second
detected, rescanning may
appointment may be needed
be carried out by another
for completion of
doctor to confirm the
examination if the foetus is
diagnosis. In case of life
in a position which makes
threatening anomalies, for
scanning difficult or if the
example anencephaly of
image is not very clear as in
foetus, termination of
larger women. The best time
pregnancy can be suggested.
to do this scan is around 20
weeks of pregnancy because
If the problem requires
the baby's parts are not
surgery soon after birth, for
Figure: A foetal anomaly scans at 21 weeks.
crowded and easily seen.
example gastroschisis, then
The scan usually takes about
preparations are made for
20 minutes.
surgery to be done after birth. If the abnormality is
associated with chromosomal abnormality, then
An anomaly scan will detect approximately 50% of
cordocentesis will be performed to determine the
significant abnormalities Their early detection enables
karyotype.
The table below shows the major anomalies and their percentage chances of being detected.
Problem
What the problem is
Spina bifida
Open spinal cord
Anencephaly
Absence of the top of the head
Hydrocephalus
Excess fluid within the brain
Major congenital heart problems
Diaphragmatic hernia
A defect in the muscle which separates the chest
and abdomen
Exomphalos/gastroschisis
Defects of the abdominal wall
Major kidney problems
Missing or abnormal kidneys
Major limb abnormalities
Missing bones or very short limbs
Cerebral palsy
Spasticity
Autism
Downs syndrome
May be associated with heart and bowel problems
Reference: Royal College of Obstetrics and Gynaecologists (2000)
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Chance of being seen
90%
99%
60%
25%
60%
90%
85%
90%
Never seen
Never seen
About 40%

May 2009, Vol. 34, Issue 2

Diagnosis of Helicobacter pylori Infection
Sadia Omer, Microbiology

H. pylorus is a helix-shaped gram-negative pathogen
responsible for gastritis, peptic ulcer disease and gastric
MALTomas in humans. It is also associated with the
development of gastric adenocarcinoma.
Approximately 50percent of the world's population is
affected by gastric H. pylori infection. Infection is more
frequent in less developed countries like Pakistan, India
and Bangladesh. Many invasive and non-invasive
methods are available for the detection of H. pylori
infection. If done properly all of these methods have a
diagnostic accuracy of more than 95%. However, each
test has its advantages and disadvantages.
NON INVASIVE METHODS
Serology (Blood Antibody Test)

more difficult. However this test is not locally available
up till now.
Stool Antigen Test
Stool antigen-testing allows non-invasive detection of
H. pylori that is indicative of active infection. A positive
result on the stool antigen test seven days after
completion of therapy identifies patients in whom
eradication of H. pylori was unsuccessful. The
sensitivity of this test ranges from 86-94% and has a
specificity of 92-97%. However it is not a quantitative
test and like the serological test it does not help in the
determination of lesion or pathology and has no
antimicrobial susceptibility. This test is available at
AKUH laboratories.

Urea Breath Test
Titers of serum
immunoglobulin IgG and
Urea breath test is an
less frequently IgA to H.
e ff e c t i v e d i a g n o s t i c
pylori is a quick and
method for H. pylori.
readily available
Results of these assays
modality for diagnosis.
correlate with numbers
The sensitivity of this test
of urease producing
is 76-84percent which is
H. pylori organisms.
more sensitive than
This is the most valuable
biopsy as in essence it
test for assessing
samples the entire
response to eradication
stomach. The biopsy only
therapy after 6 to 8
samples a small region
weeks. It hasa sensitivity
and since the
of 90-95% and a
inflammatory process
specificity of 94-100%
may be patchy, it may be
Figure 1: Helicobacter pylori H&E Stain
But the drawback of this
missed. However it does
Courtesy Dr M Abrar Barakzai (Histopathology Section, AKUH)
test is that it is expensive,
not help in the
involves administration
determination of lesion or
of radioisotopes and is
pathology and has no
not quantitative.
antimicrobial susceptibility. This test is available at
AKUH laboratories.
INVASIVE METHODS
Detection of Salivary H. Pylori Antibody
Endoscopy with Biopsy
IgG antibodies detection from saliva could be used
The gold standard method for detecting H. pylori
reliably for screening dyspeptic patients in general
infection is a biopsy taken during an endoscopy. This
practice, especially in children in whom venesection is

11
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permits the inspection of pathology and allows the
detection of ulcers, strictures and neoplasm. Biopsy
specimens may be cultured for H. pylori but require
expertise and resources. Another advantage is that
antibiotic susceptibility testing could be performed.
However it is an expensive and invasive procedure, and
as compared to other diagnostic modalities is time
consuming.

Molecular Methods
PCR for the detection of H.pylori in tissue biopsy
samples is available. Moreover polymerase chain
reactions are available that could detect resistance genes
and could therefore give an idea about the antimicrobial
susceptibilities. However these tests are not widely
available and are a research tool at this moment.

Hepatitis C Virus (HCV) Genotyping
Afsheen M. Ibrahim, Molecular Pathology
HCV has infected nearly 170 million people worldwide.
Out of this, 3/4 million are newly infected. There are
about 30percent cases of acute hepatitis and 80percent
cases of chronic hepatitis that develop a risk of cirrhosis
and hepatocellular carcinoma.

classified into six main genotypes (1a-6a) and several
subtypes (1a, 1b etc). The most common genotype in
Asia including Pakistan is 3a.

Envelope glycoprotein 2
Envelope glycoprotein 1

Envelope lipid
RNA genome

Capsid proteins

Figure 1: Model structure of HCV

The hepatitis C virus is a small 15 nm, enveloped, single
stranded, positive sense RNA virus. It is a member of
hepacivirus genus in the family flaviviridae. HCV
genome is approximately 10,000 nucleotides which
codes for 3,000 amino acids.
Due to different genetic variations several different
strains of HCV are identified, called genotypes. With the
advent of advanced molecular tests, HCV genome is

12

Genotype information is important for patient
management and prediction of treatment response. A
genotype test requires a blood sample. RNA is extracted
from serum and reverse transcribed (RT) to cDNA and
amplified using polymerase chain reaction (PCR). The
PCR product is denatured and hybridized to the
nitrocellulose strip with HCV genotypes already bound
to it. After hybridization of PCR product with the strip,
conjugate is applied and substrate is added resulting in
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purple brown precipitate. A
line is considered positive
when a distinct brown spot
appears on the strip as shown
in figure 2.
The success rate of antiviral
treatment (Interferon plus
Ribavirin) ranges from 5090%. Genotype 1 has least
response (50%) to therapy
while genotype 2 and 3 show
best response (nearly 90%).
Genotype of a person remains
the same throughout the
treatment unless person is reinfected with another
genotype.

4

3a

3a

N

2

1a

Conjugate control line
(CONJ CTRL)
5'UTR amplification
control line
(AMPL CTRL 1)

19 genotype specific
lines

Core amplification
control line
(AMPL CTRL 2)

3 genotype specific lines

At Aga Khan University
Hospital, Molecular
Pathology Section of Clinical
Laboratory, HCV in serum is
tested by RNA extraction and
amplification using Amplicor
HCV assay and HCV positive
samples are then genotyped
using Linear Array HCV
genotyping kit based on
hybridization to genotype
specific probes.

Figure 2: Banding pattern of genotypes on different strips.

Answer to Haematology Quiz
Drs Natasha Ali, Kashif Khan, Haematology
Peripheral blood film shows characteristic large
granules in neutrophil (left) and monocyte (right)
seen in Chediak Higashi syndrome.
Chediak Higashi syndrome is a fatal inherited
autosomal recessive disorder characterised by a
defect in formation of lysosomes in multiple cell
lineages. Abnormally large granules in leucocytes
and other granule containing cells is the hallmark
characteristic and diagnostic feature.

Haematological abnormalities are most apparent in
the granulocytic series although anaemia and
thrombocytopenia also occur. Homozygotes for
defective genes suffer from partial albinism,
neurological abnormalities, and recurrent bacterial
infections.
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